Matsuda Masaru
See Remarks | See Remark | SVP And General Counsel +1 more
2 companies
Insider Signal Score
51
AverageTrades Analyzed
23
12M Win Rate
29.4%
Avg 3M Return
-12.3%
Avg 12M Return
-28.6%
Matsuda Masaru is a See Remarks at Arcutis Biotherapeutics, Inc. with holdings across 2 companies. Recent SEC Form 4 filings include 0 buys and 16 sells.
Estimated insider holdings value: $4.9M based on current market prices.
Holdings by Company
Transaction History
Showing 10 filings
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| May 4, 2026 | ARQT Arcutis Biotherapeutics, Inc. | See Remarks | Sell | 8,256 | $23.31 | $192,415.26 | -3.1% | - | - | |
| Feb 2, 2026 | ARQT Arcutis Biotherapeutics, Inc. | See Remarks | Sell | 40,638 | $25.28 | $1,027,292.65 | -7.5% | -8.7% | - | |
| Dec 1, 2025 | ARQT Arcutis Biotherapeutics, Inc. | See Remarks | Sell | 1,657 | $30.23 | $50,091.11 | -1.1% | -18.5% | - | |
| Nov 19, 2025 | ARQT Arcutis Biotherapeutics, Inc. | See Remarks | Sell | 2,550 | $28.29 | $72,135.10 | -0.8% | -4.6% | - | |
| Nov 3, 2025 | ARQT Arcutis Biotherapeutics, Inc. | See Remarks | Sell | 7,208 | $24.72 | $178,155.76 | -2.3% | +3.3% | - | |
| Sep 4, 2025 | ARQT Arcutis Biotherapeutics, Inc. | See Remarks | Sell | 36,130 | $16.16 | $583,716.28 | -18.3% | +84.8% | - | |
| Aug 4, 2025 | ARQT Arcutis Biotherapeutics, Inc. | See Remarks | Sell | 6,330 | $14.33 | $90,687.38 | -3.1% | +70.5% | - | |
| May 28, 2025 | ARQT Arcutis Biotherapeutics, Inc. | See Remarks | Sell | 1,800 | $13.78 | $24,806.52 | -0.9% | +16.6% | +57.9% | |
| May 2, 2025 | ARQT Arcutis Biotherapeutics, Inc. | See Remarks | Sell | 5,030 | $15.20 | $76,453.49 | -2.4% | -4.3% | +53.2% | |
| Mar 3, 2025 | ARQT Arcutis Biotherapeutics, Inc. | See Remarks | Sell | 3,263 | $13.03 | $42,520.48 | -1.5% | +5.1% | +83.9% |
Page 1Next →